Circular RNA 0010117 promotes aggressive glioblastoma behavior by regulating the miRNA-6779-5p/SPEN axis

Xuanyong Yang1, Yue Liu1, Xinhui Zhou2

  • 1Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, China.

Translational Oncology
|September 10, 2022
PubMed

Insights

Circular RNA 0010117 (circ-0010117) is downregulated in glioblastoma and suppresses tumor growth. This circular RNA regulates glioblastoma aggressiveness via the miR-6779-5p/SPEN axis, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Noncoding RNAs (ncRNAs) are crucial in cancer biology.
  • Circular RNAs (circRNAs) are a novel class of ncRNAs implicated in glioblastoma progression.
  • Mechanisms linking circRNAs to glioblastoma remain largely unknown.

Purpose of the Study:

  • To investigate the expression and function of circRNA 0010117 (circ-0010117) in glioblastoma.
  • To elucidate the molecular mechanisms by which circ-0010117 influences glioblastoma aggressiveness.
  • To evaluate circ-0010117 as a potential therapeutic target for glioblastoma.

Main Methods:

  • Quantitative RT-PCR and Western blotting for expression analysis.
  • In vitro cell-based assays and in vivo xenograft models for functional studies.
  • Bioinformatics, luciferase reporter assays, and functional complementation to identify targets.

Main Results:

  • circ-0010117 was found to be downregulated in glioblastoma tissues.
  • circ-0010117 suppressed glioblastoma cell aggressiveness by regulating miR-6779-5p.
  • SPEN was identified as a direct target of miR-6779-5p, forming the circ-0010117/miR-6779-5p/SPEN axis.
  • Overexpression of circ-0010117 inhibited tumor growth in vivo.

Conclusions:

  • circ-0010117 suppresses glioblastoma progression by modulating the miR-6779-5p/SPEN pathway.
  • circ-0010117 represents a promising novel therapeutic target for glioblastoma treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.3K